Tobias Hase / dpa
The product has an efficiency of 100% for this tranche.
The Swiss Institute of Swiss Medical Products has been teaching adults between the ages of 12 and 15 to authorize the Pfizer / BioNTech vaccine to prevent Covid-19.
The Institute for the Surveillance of the Therapeutic Products Market in Switzerland will have a precise examination of this extension, deposited on May 7 by Pfizer, in the framework of an evolutionary rapid procedure.
Adolescents who participate in this clinical course have the same dose as adults. The immune response that was developed was comparable to that of the participants plus the events that took place between the ages of 16 and 25. As for the more than 16-year-olds, the administrator administers two doses of serum.
The number of secondary effects observed in adolescents, they corresponded to the same number of declared clinical examinations for 16-25 years and adults. The plus frequencies are due to the injectors of the injection, a general fatigue, the most of the head, the freesons, the curves, the fever and the articulators.
These effects are indescribable, which can be increased after the administration of the second dose, disparate with the general rule in three days plus tard.